Interim Analysis of Pregnancy Outcomes After Exposure to Dimethyl Fumarate in a Prospective International Registry

BACKGROUND AND OBJECTIVES: Oral delayed-release dimethyl fumarate (DMF) is not recommended during pregnancy and should only be used if the potential benefit justifies the potential fetal risk. Although DMF was well tolerated in clinical trials with consistent safety results in postmarketing surveill...

Descripción completa

Detalles Bibliográficos
Autores principales: Hellwig, Kerstin, Rog, David, McGuigan, Christopher, Houtchens, Maria K., Bruen, Denise R., Mokliatchouk, Oksana, Branco, Filipe, Peng, Xiaomei, Everage, Nicholas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611504/
https://www.ncbi.nlm.nih.gov/pubmed/34815321
http://dx.doi.org/10.1212/NXI.0000000000001114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611504/
https://www.ncbi.nlm.nih.gov/pubmed/34815321
http://dx.doi.org/10.1212/NXI.0000000000001114

Ejemplares similares